We narrowed to 4,669 results for: gca

#195856

E. coli nonsense suppressor strain (serU) transformed with plasmid carrying chromogenic protein (CP) with amber nonsense mutation in chromophore. Grows salmon when CP is induced with rhamnose.

Gregory Phillips

DeWolf et al J Microbiol Biol Educ. 2023 Oct 25;24(3)

Feb. 8, 2023

Academic Institutions and Nonprofits only

#176586

E. coli BL21 strain (with recBCD genomic locus deleted) for making cell-free extracts for Linear DNA expression. Contains pRARE2 + pBADmod1-linker2-gamS plasmids.

Jean-Loup Faulon

Batista et al ACS Synth Biol. 2022 Jan 16. doi: 10.102

Dec. 14, 2021

Academic Institutions and Nonprofits only

#141407

LacI-deficient E. coli host bacterium that produces β-galactosidase constitutively

Antal Kiss

Szentes et al Nucleic Acids Res. 2020 Mar 18;48(5):e28

Aug. 4, 2020

Academic Institutions and Nonprofits only

#197656

Derivative of BL21(DE3) with the serC gene knocked out. This strain is used for expressing proteins containing site-specific non-hydrolyzable phosphoserine.

Richard Cooley, Ryan Mehl

Zhu et al ACS Cent Sci. 2023 Apr 10;9(4):816-835.

April 26, 2023

Academic Institutions and Nonprofits only

#196903

RNase III-His is an E. coli strain made for a cell-free expression system.

Kate Adamala

Sato et al Biotechnol Bioeng. 2023 Jul;120(7):1986-

Aug. 22, 2025

Academic Institutions and Nonprofits only

#197655

This strain is used for expressing phosphoserine-containing proteins using genetic code expansion without buildup of prematurely truncated protein.

Richard Cooley, Ryan Mehl

Zhu et al ACS Chem Biol. 2019 Jul 19;14(7):1564-15

March 16, 2023

Academic Institutions and Nonprofits only

#237425

This engineered E. coli S17-1 λpir strain, featuring a mutation in the gyrA gene (462Arg→Cys), was designed to confer resistance to the CcdB toxin, allowing it to survive with a ccdB-carrying plasmid.

Xue Liu

Zhang et al Nat Commun. 2025 Jul 1;16(1):5870. doi:

Aug. 7, 2025

Academic Institutions and Nonprofits only

#105598-AAV5

Ready-to-use AAV5 particles produced from pAAV.GfaABC1D.PI.Lck-GFP.SV40 (#105598). In addition to the viral particles, you will also receive purified pAAV.GfaABC1D.PI.Lck-GFP.SV40 plasmid DNA. GfaABC1D-driven GFP expression control. These AAV preparations are suitable purity for injection into animals.

Baljit Khakh

Shigetomi et al J Gen Physiol. 2013 Apr 15.

March 8, 2018

Academic Institutions and Nonprofits only

#44332-AAV5

Ready-to-use AAV5 particles produced from pZac2.1 gfaABC1D-tdTomato (#44332). In addition to the viral particles, you will also receive purified pZac2.1 gfaABC1D-tdTomato plasmid DNA. GfaABC1D-driven tdTomato expression control. These AAV preparations are suitable purity for injection into animals.

Baljit Khakh

Shigetomi et al J Gen Physiol. 2013 Apr 15.

April 12, 2018

Academic Institutions and Nonprofits only